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1. Introduction 
The inhibitory action and binding characteristics 
of the new anti-fungal antibiotic myxothiazol has been 
described in [ 1,2]. Like antimycin, myxothiazol binds 
very tightly, inhibiting the electron flow completely 
at a titer of -1 mol inhibitor/m01 complex III. How- 
ever, myxothiazol binds to a site other than that of 
antimycin, as indicated by a red shift of the ferrocyto- 
chrome b spectrum. The myxothiazol shift is indepen- 
dent of and differs from the antimycin red shift. 
myxothlazol 
CkH3 bCH3 
Myxothiazol contains a bis-thiazol system as a 
predominant structural element. Besides it contains 
an E-/3-methoxyacrylate system as a terminal segment. 
The rest of the molecule is linked in /3’-position to 
acrylic acid, present as amide [3,4] (fig.1). 
strobilurln A: H H IS 
B: CH30 Cl 
This study describes the inhibitory action and 
binding behavior of three further new antifungal anti- 
biotics: oudemansin, strobilurin A and strobilurin B, 
and compares them with myxothiazol and antimycin. 
Like myxothiazol, all three molecules comprise an 
E-fl-methoxyacrylate system (moa-system) as a struc- 
tural element, but in these three antibiotics the rest 
of the molecule is linked in ol-position to the acrylic 
acid, present here as methylester. The four antibiotics 
containing the moa-systems are termed moa-inhibitors 
in the following. Oudemansin has been isolated from 
Oudemansiella mucida [5], the strobilurins from Stro- 
bilurus tenacehs [6]. The strobilurins differ from each 
other in their substituents at the benzyl ring; oude- 
mansin, when compared to strobilurin A, has an added 
methanol to Agy”. The relative configuration of the 
Fig.]. Structural formulae of the moa-inhibitors of the bc, 
segment of the respiratory chain containing the EQ-methoxy- 
acrylate system as common structural element. 
crystalline oudemansin has been elucidated by X-ray 
analysis [7], permitting the discussion of a probable 
structure-function relationship. 
2. Materials and methods 
Myxothiazol was a generous gift from Dr H. 
Reichenbach (Gesellschaft fiir Biotechnologische For- 
schung, Braunschweig). Oudemansin, strobilurin A 
and strobilurin B were isolated at the Lehrbereich 
Spezielle Botanik (University of Tiibingen). Antimycin 
and all other biochemical reagents were purchased from 
Boehringer (Mannheim). 
t This publication is part of the PhD thesis of W. F. Becker 
The inhibitors were dissolved in ethanol. The absor- 
bance coefficients used were 4.8 mM_' . cm-’ at 320 
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nm for antimycin [2], 10.5 rnM_l. cm-l at 3 13 nm 
for myxothiazol [2], 30.2 mM_’ cm-’ at 245 nm for 
oudemansin [5], 2 1.8 rnM_l. cm-l at 294 nm for stro- 
bilurin A and 28.4 mM_' . cm-’ at 304 nm for strobi- 
lurin B [6]. 
Submitochondrial particles from beef heart were 
prepared as in [2]. Complex III was isolated according 
to [ 111, and the bcr-complex devoid of iron-sulfur 
protein according to [ 121. 
3. Results 
3.1. Inhibition of electron flow 
Oudemansin and the strobilurins inhibit electron 
flow in a similar fashion, as demonstrated by the inhi- 
bition of the NADH oxidation of submitochondrial 
particles (fig.2). Oudemansin binds with low affinity. 
Titrations were performed at 56 pg protein/ml, corre- 
sponding to 18 nM complex III. The oudemansin titra- 
tion curve can be simulated by a mass action plot if it 
is assumed that the concentration of the free inhibitor 
roughly equals that of the added inhibitor. The best 
fit of the titration curve is obtained with an app. 
Kd = 5 X 10m7 M. The strobilurins bind more tightly 
than oudemansin; the Kd-values have not yet been 
estimated. 
As is well known, antimycin inhibits in amounts 
nearly stoichiometric to complex III, since it binds 
with K, -lO-1’ M [8]. The myxothiazol binding is 
not much lower than that of antimycin. Concerning 
the Kd-values one must remember that they may be 
influenced substantially by a partition of the hydro- 
phobic antibiotics between the phospholipid phase 
of the particles and the aqueous phase of the incuba- 
tion medium; the actual Kd-values may in fact be 
higher [9]. 
3.2. Characterization of the primary site of action of 
the various inhibitors by difference spectropho- 
tometry 
The site of action can be traced by difference spec- 
trophotometry: the redox components before the 
block are in the reduced state, while those behind the 
block are in the oxidized state. In these experiments a 
spectrum where the cytochromes are completely 
reduced by dithionite on the sample side and fully 
oxidized by ferricyanide on the reference side, serves 
as reference (iig.3). In the subsequent spectra the 
oudemansin 
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Fig.2. Inhibition of the NADH oxidation of beef heart submitochondrial particles by the various moa-inhibitors and by antimycin. 
The NADH oxidation was observed by difference spectrophotometry with 340 nm as measuring and 420 nm as reference wavelength. 
The rates were measured with 1 mM NADH, V,,, = 1.05 X lo3 Mmol/min X g protein at 25°C. 
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Fig.3. Difference absorbance spectra of beef heart submito- 
chondrial particles in the dithionite- and NADH-reduced ana- 
erobic state and in the NADH-reduced aerobic states blocked 
by the various inhibitors. The particle concentration was 
1.7 mg protein/ml, corresponding to 1.02 MM heme b. The 
additions were: 1 mM NADH, 15 nM antimycin, 160 nM 
strobilurin A, 44 PM strobilurin B and 280 nM oudemansin. 
reference side is in the oxidized state. In the anaerobic 
state with NADH as electron donor, cytochromes cr 
and ua3 are nearly completely reduced, while cyto- 
chrome b is reduced to -60%. With oudemansin and 
the strobilurins, cytochrome b preserves its degree of 
reduction, while cytochromes ci and 4~2~ change to a 
completely oxidized state. The antimycin spectrum 
differs from the oudemansin and strobilurin spectra 
in its complete degree of cytochrome b reduction. 
The experiments show that all three inhibitors 
block the electron transfer between cytochrome b 
and cytochrome cr but, in contrast to antimycin, the 
moa-inhibitors cause a reduction of only -50% of 
cytochrome b (myxothiazol not shown, cf. [ 11). This 
difference in the degree of cytochrome b reduction 
provides a hint that antimycin and the moa-inhibitors 
may act differently. 
3.3. The different bathochromic shifts of the absor- 
bance spectrum of ferrocytochrome b induced 
by the binding of the various inhibitors 
As described for antimycin and myxothiazol, the 
binding of the inhibitors causes a bathochromic shift 
of the o-absorbance spectrum of reduced cytochrome 
b. The maximum-minimum shift spectra can be ana- 
lyzed quantitatively. In the case of antimycin [lo] 
and myxothiazol [2] the analysis indicates a linear 
binding and saturation of the binding site at 1 mol 
inhibitor/mol complex III. The red-shifts of the moa- 
inhibitors were tested with complex III isolated in 
Triton X-l 00 by means of hydroxyapatite chromatog- 
raphy followed by gel chromatography [ 111. Experi- 
ments with the isolated complex give signals at a height 
suitable for quantitative analysis, even when the shift 
is very minor as in the case of myxothiazol. The exper- 
iments were performed with completely reduced com- 
plex in both sample and reference cuvettes, and addi- 
tion of inhibitor to the sample cuvette. The red-shifts 
of the various moa-inhibitors compete with each other 
(not shown) whereas the red shift of antimycin is 
independent from and additive to those of the moa- 
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Fig.4. Independence of the antimycin-and oudemansin-induced 
red shifts of isolated beef heart complex III, reflecting the 
independent binding of the two inhibitors. The complex con- 
centration was 1.6 mg protein/ml, corresponding to 11 PM 
heme b; 280 nM oudemansin and 15 nM antimycin were added. 
Trace: (1) base line before addition of inhibitors; (2) oude- 
mansin-induced red shift; (3) base line with oudemansin in 
both cuvettes; (4) antimycin-induced red shift; (5) base line 
with oudemansin plus antimycin in both cuvettes. 
inhibitors. Fig.4 shows the independence of the anti- 
mycin red shift from that of oudemansin. Trace 1 
gives the base line originating from a difference spec- 
trum of the dithionite-reduced complex. Trace 2 shows 
the symmetric spectrum of the red shift as induced 
by saturating concentrations of oudemansin. The 
absorbance maximum lies at 568 nm, the minimum 
at 558 nm. Subsequent addition of oudemansin to 
the reference side abolishes the spectrum (trace 3). 
The red shift spectrum of antimycin can now be 
induced by addition of antimycin to the sample side 
(trace 4). The same spectra can be reached by the 
reverse sequence of additions. Finally a base line can 
be re-established by addition of antimycin to the 
reference cuvette (trace 5). The antimycin red shift 
can also be obtained by adding antimycin after myxo- 
thiazol or the strobilurins. The spectral data of the red 
shifts caused by the other moa-inhibitors will be 
published later. 
Fig.5 gives binding curves of antimycin in the pres- 
ence and absence of the moa-inhibitors. The signal 
L 5 6 7 
antimycin [10-6M] 
Fig.5. Antimycin titrations of the red shift of ferrocytochrome 
b of isolated beef heart complex III in the presence and absence 
of the moa-inhibitors. The concentration of isolated complex 
III was 1.2 mg protein/ml, corresponding to 8.4 PM heme b: 
(*-_*) no addition; (o-o) 140 PM oudemansin; (o-o) 
280 PM oudemansin; (A-A) 160 nM strobilurin A; (+-_*) 
44 bM strobilurin B. 
height of the antimycin red shift is only slightly 
changed by the binding of the other inhibitors, while 
the titer for full saturation and the binding affinity 
for antimycin are not altered. The experiments demon- 
strate that antimycin and the moa-inhibitors bind to 
different sites. In addition to the a-red shift, the inhi- 
bitors induce alterations in the y-absorbance bands of 
ferri- and ferrocytochrome b, as will be described later. 
The complex III preparation containing bound anti- 
mycin and lacking the iron-sulfur-carrying peptide 
[ 121 still binds the moa-inhibitors as indicated by the 
respective red shifts (unpublished). 
4. Discussion 
The recent elucidation of the DNA sequence of 
the mitochondrial cytochrome b gene [ 13,141 together 
with the partial amino acid sequence of the isolated 
cytochrome b peptide [ 151 give strong support to the 
existence of only one cytochrome b molecule in com- 
plex III, possessing an Mr of -43 000. This molecule 
shelters two different heme b centers [ 13,151. Absor- 
bance and EPR data give some indication that antimy- 
tin influences mainly the ligand field of the bK center 
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In view of the independence of the antimycin-induced 
and the moa-inhibitor-induced red shifts shown here, 
it is tempting to speculate that the moa-inhibitors have 
a pronounced influence on the other heme center, 
namely the bT center. Further experiments will have 
to elucidate this question, just as it will have to be 
clarified whether the moa-inhibitors act competitively 
with ubiquinol or semiquinone, or whether they react 
at a site not identical with the catalytic center(s) of 
cytochrome b. 
Preliminary inhibition experiments reveal that the 
moa-segment is essential for the biological action, e.g., 
dimethyl myxothiazol has only 1% of the inhibitory 
action of myxothiazol [2]. The relative configuration, 
i.e., the three-dimensional form of the oudemansin 
molecule when it is in crystalline array has been eluci- 
dated and shown in an ORTEP stereoplot [5]. The 
molecule is arranged along two planes which form an 
angle of 78”. One plane is formed by the terminal 
styryl moiety, the other by the terminal E-/3-methoxy- 
acrylate system. Due to the steric hindrance, the rota- 
tion around the 9,lO single bond is restricted, there- 
fore the configuration in the aqueous phase may be 
very similar to the crystalline state. Thus the low bind- 
ing affinity of oudemansin may be induced by a hind- 
rance of the interaction of the moa-system with the 
binding site due to an impeded accessibility of the 
system in the relatively rigid molecule. The strobilurins 
may bind more tightly, since all 7 double bonds are in 
a conjugated state, leading to a planar configuration 
of the molecule. Myxothiazol finally, the most tightly 
binding inhibitor, possesses a moa-system substituted 
in $-position with an unconjugated double bond of 
the acrylic acid. In this way the moa-system achieves 
a relatively high mobility, facilitating the adaption of 
the key (moa-system) to the lock (the specific binding 
site). 
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